Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection

Sci Rep. 2023 Nov 23;13(1):20631. doi: 10.1038/s41598-023-48001-y.

Abstract

The prevalence of Mycobacterium avium complex-pulmonary disease (MAC-PD) has become a growing concern worldwide, and current treatments involving macrolides (clarithromycin [CLR] or azithromycin), ethambutol, and rifampicin have limited success, highlighting the need for better therapeutic strategies. Recently, oxazolidinone drugs have been identified as novel anti-tuberculosis drugs effective against drug-resistant M. tuberculosis. However, the effects of these drugs against MAC are still controversial due to limited data. Here, we first evaluated the intracellular anti-MAC activities of two oxazolidinone drugs, linezolid (LZD) and delpazolid (DZD), against 10 macrolide-susceptible MAC strains and one macrolide-resistant M. avium strain in murine bone marrow-derived macrophages (BMDMs) and found that both drugs demonstrated similar potential. The synergistic efficacies with CLR were then determined in a chronic progressive MAC-PD murine model by initiating a 4-week treatment at 8 weeks post-infection. Upon assessment of bacterial burdens and inflamed lesions, oxazolidinone drugs exhibited no anti-MAC effect, and there was no significant difference in the synergistic effect of CLR between LZD and DZD. These findings suggest that oxazolidinone drugs inhibit intracellular bacterial growth, even against macrolide-resistant MAC, but their clinical application requires further consideration.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antitubercular Agents / pharmacology
  • Clarithromycin / therapeutic use
  • Humans
  • Lung Diseases* / drug therapy
  • Macrolides / pharmacology
  • Mice
  • Mycobacterium avium Complex
  • Mycobacterium avium-intracellulare Infection* / drug therapy
  • Mycobacterium avium-intracellulare Infection* / microbiology
  • Oxazolidinones* / pharmacology
  • Oxazolidinones* / therapeutic use

Substances

  • Oxazolidinones
  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Clarithromycin
  • Macrolides